Statements or guidelines from WHO, CDC, or other major health organizations

Didier Raoult's IHU Hydroxychloroquine Study Officially Retraction After Five-Year COVID-19 Controversy

Dec 17, 2024, 01:00 PM

The prominent study on hydroxychloroquine for COVID-19, led by Professor Didier Raoult and his team at the IHU Méditerranée Infection in Marseille, has been officially retracted. This research had been a cornerstone for proponents of the drug as a treatment against COVID-19. The retraction marks a significant development in the ongoing debate over the efficacy of hydroxychloroquine, which has faced scrutiny regarding its methodology and conclusions. The study, which had been defended by Raoult and his colleague Philippe Gautret, has been invalidated after nearly five years of controversy surrounding its claims. Critics have long argued that the study should have been retracted much earlier, reflecting the contentious nature of hydroxychloroquine's role in the pandemic response.